JP2006160721A5 - - Google Patents

Download PDF

Info

Publication number
JP2006160721A5
JP2006160721A5 JP2005048198A JP2005048198A JP2006160721A5 JP 2006160721 A5 JP2006160721 A5 JP 2006160721A5 JP 2005048198 A JP2005048198 A JP 2005048198A JP 2005048198 A JP2005048198 A JP 2005048198A JP 2006160721 A5 JP2006160721 A5 JP 2006160721A5
Authority
JP
Japan
Prior art keywords
recovery agent
fatigue recovery
cerebral fatigue
active ingredient
chlorogenic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2005048198A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006160721A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2005048198A priority Critical patent/JP2006160721A/ja
Priority claimed from JP2005048198A external-priority patent/JP2006160721A/ja
Priority to KR1020077010085A priority patent/KR20070083944A/ko
Priority to US11/718,894 priority patent/US20070270497A1/en
Priority to EP05806145A priority patent/EP1810671A4/en
Priority to PCT/JP2005/020432 priority patent/WO2006051773A1/ja
Priority to TW094139278A priority patent/TW200621281A/zh
Publication of JP2006160721A publication Critical patent/JP2006160721A/ja
Publication of JP2006160721A5 publication Critical patent/JP2006160721A5/ja
Priority to US12/493,605 priority patent/US20090264524A1/en
Withdrawn legal-status Critical Current

Links

JP2005048198A 2004-11-09 2005-02-24 大脳疲労回復剤 Withdrawn JP2006160721A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP2005048198A JP2006160721A (ja) 2004-11-09 2005-02-24 大脳疲労回復剤
KR1020077010085A KR20070083944A (ko) 2004-11-09 2005-11-08 대뇌 피로 회복제
US11/718,894 US20070270497A1 (en) 2004-11-09 2005-11-08 Agent For Recovery From Cerebral Fatigue
EP05806145A EP1810671A4 (en) 2004-11-09 2005-11-08 MEANS FOR RECOVERY AFTER ZEREBRALER FATIGUE
PCT/JP2005/020432 WO2006051773A1 (ja) 2004-11-09 2005-11-08 大脳疲労回復剤
TW094139278A TW200621281A (en) 2004-11-09 2005-11-09 Cerebral fatigue recovery agent
US12/493,605 US20090264524A1 (en) 2004-11-09 2009-06-29 Agent for recovery from cerebral fatigue

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004324516 2004-11-09
JP2005048198A JP2006160721A (ja) 2004-11-09 2005-02-24 大脳疲労回復剤

Publications (2)

Publication Number Publication Date
JP2006160721A JP2006160721A (ja) 2006-06-22
JP2006160721A5 true JP2006160721A5 (enExample) 2008-04-17

Family

ID=36336452

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005048198A Withdrawn JP2006160721A (ja) 2004-11-09 2005-02-24 大脳疲労回復剤

Country Status (6)

Country Link
US (2) US20070270497A1 (enExample)
EP (1) EP1810671A4 (enExample)
JP (1) JP2006160721A (enExample)
KR (1) KR20070083944A (enExample)
TW (1) TW200621281A (enExample)
WO (1) WO2006051773A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034410B2 (en) * 2011-08-22 2015-05-19 Thomas J. Vella Whole green coffee bean products and methods of production and use
TW201733619A (zh) * 2015-12-16 2017-10-01 Suntory Holdings Ltd 肌肽二肽酶阻礙用組成物
JP2018039797A (ja) * 2016-09-02 2018-03-15 花王株式会社 脳機能改善剤
CN111758841B (zh) * 2020-08-19 2023-07-28 上海俏贝丽宠物用品有限公司 促进幼犬猫智力发育的组合物、添加剂、保健品及其制备方法
CN115067450A (zh) * 2022-05-24 2022-09-20 广东橘香斋大健康产业股份有限公司 一种营养补充型抗疲劳固体饮料及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3916028A (en) * 1972-07-28 1975-10-28 Gen Foods Corp Sweetness inducer
US3924017A (en) * 1972-07-28 1975-12-02 Gen Foods Corp Sweetness inducer
US4145255A (en) * 1977-02-25 1979-03-20 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Method and device for the detection of phenol and related compounds
DE3603574C1 (de) * 1986-02-06 1987-07-23 Ergo Forschungsgmbh Verfahren zur Gewinnung von Chlorogensaeure
DE3603576A1 (de) * 1986-02-06 1987-08-13 Code Kaffee Handel Verwendung von gerbstoffen und/oder chlorogensaeure sowie nahrungs-, genuss- und/oder arzneimittel mit gerbstoff- und/oder chlorogensaeurezusatz
JPS62277326A (ja) * 1986-05-24 1987-12-02 Zeria Shinyaku Kogyo Kk 脳機能改善剤
US5788971A (en) * 1993-10-21 1998-08-04 Sky. Food Co., Ltd. Active oxygen free radical scavenging agent
US5958417A (en) * 1996-10-24 1999-09-28 Hsu; Chau-Shin Herbal combinations
JP4210364B2 (ja) * 1998-04-22 2009-01-14 花王株式会社 自律神経機能向上剤及び食品
US6458392B1 (en) * 2000-07-12 2002-10-01 Kao Corporation Preventive, alleviative or remedy for hypertension
JP3548102B2 (ja) * 2000-08-07 2004-07-28 花王株式会社 高血圧症予防・治療剤
US6991812B2 (en) * 2000-09-05 2006-01-31 Kao Corporation Agent for preventing, improving or treating hypertension
JP4077149B2 (ja) * 2000-11-02 2008-04-16 花王株式会社 自律神経機能向上剤
US6632459B2 (en) * 2000-12-11 2003-10-14 Nutricia N.V. Chlorogenic acid and an analog thereof for immune system stimulation
JP2002363075A (ja) * 2001-06-05 2002-12-18 Kao Corp 高血圧症予防・治療剤
ITMI20022389A1 (it) * 2002-11-12 2004-05-13 Nicox Sa Farmaci per le disfunzioni sessuali.
US20070178176A1 (en) * 2006-02-02 2007-08-02 Chithan Kandaswami Composition and method for promoting weight loss

Similar Documents

Publication Publication Date Title
ZA200902632B (en) Haloalkylsufonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide
JP2009084295A5 (enExample)
WO2008149802A1 (ja) アンドログラホリドを有効成分とする抗疲労剤及び経口組成物
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
WO2006135480A3 (en) Oral pharmaceutical formulations comprising fenofibric acid and/or its salts
JP2007523049A5 (enExample)
WO2008134828A3 (en) Tissue degeneration protection
RU2010136914A (ru) Средство и продукт питания для профилактики/уменьшения проявлений функционального расстройства пищеварения
JP2007523135A5 (enExample)
JP2014218522A5 (enExample)
JP2006160721A5 (enExample)
JP2008266291A5 (enExample)
JP2009139371A5 (enExample)
EP2392337A3 (en) Use of 24-norUDCA
JP2006342148A5 (enExample)
JP2010526884A5 (enExample)
TW200640446A (en) Prophylactic anti-stress agent
WO2008091618A8 (en) Use of d-ribose to treat cardiac arrhythmias
WO2006117165A3 (en) Means and methods for the treatment of head injuries and stroke
JP2005314435A5 (ja) 健康食品
JP2012097034A5 (enExample)
TW200621281A (en) Cerebral fatigue recovery agent
EP1908473A4 (en) CLARITHROMYCIN OR SALT THEREOF FOR USE IN THE TREATMENT OR PREVENTION OF PULMONARY DISEASES INDUCED BY THE DESTRUCTION OF PULMONARY ALVEOLA.
Gupta Why men die young
WO2010013798A1 (ja) ベンジルアミン誘導体又はその薬学的に許容される酸付加塩を含有する糖尿病、肥満症、脂質異常症若しくはメタボリックシンドロームの治療剤又は予防剤